Crossmark

Optimising tazobactam dosing in critically ill adult patients without renal replacement therapy: a population pharmacokinetic analysis of individual patient data pooled from multiple clinical studies

Crossref DOI link: https://doi.org/10.1186/s13054-026-06321-1

Published Online: 2026-09-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Assefa, Getnet M https://orcid.org/0000-0002-8367-5315
Roberts, Jason A.

Pea, Federico

Cojutti, Pier Giorgio

Breilh, Dominique

Carrie, Cedric

Zeitlinger, Markus

Isla, Arantxa

Tamme, Kadri

Wolie, Zenaw T

Walker, Robert J

Ulldemolins, Marta

Abdul-Aziz, Mohd H.

Liu, Xin

Sime, Fekade B. https://orcid.org/0000-0003-4061-2063
License Information

Text and Data Mining valid from 2026-09-09

Accepted Manuscript valid from 2026-09-09
More Information

Article History

Received: 6 July 2026

Accepted: 3 September 2026

First Online: 9 September 2026

Declarations

Ethics approval and consent to participate: Not applicable.

Consent for publication: Not applicable.

Competing interest: The authors declare that there is no competing interest related to this work.

Document is current

Any future updates will be listed below